Cargando…
Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice
The outcome of patients with acute venous thromboembolism (VTE) and abnormal platelet count (PlC) at baseline has not been consistently studied. In real-world clinical practice, a number of patients with abnormal PlC receive vitamin K antagonists (VKAs) to treat acute VTE despite their higher risk o...
Autores principales: | Giorgi-Pierfranceschi, Matteo, Di Micco, Pierpaolo, Cattabiani, Chiara, Guida, Anna, Pagán, Barbara, Morales, Maria del Valle, Salgado, Estuardo, Suriñach, José Maria, Tolosa, Carles, Monreal, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058956/ https://www.ncbi.nlm.nih.gov/pubmed/26632687 http://dx.doi.org/10.1097/MD.0000000000001915 |
Ejemplares similares
-
Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry
por: Di Micco, Pierpaolo, et al.
Publicado: (2019) -
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015) -
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism
por: Moustafa, Farès, et al.
Publicado: (2017) -
Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2016) -
Identification of biomarkers of venous thromboembolism by bioinformatics analyses
por: Wang, Guiming, et al.
Publicado: (2018)